$78.5 Million is the total value of Blackcrane Capital, LLC's 15 reported holdings in Q3 2021. The portfolio turnover from Q2 2021 to Q3 2021 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| FERG | FERGUSON PLC | $13,607,000 | +0.0% | 97,836 | 0.0% | 17.34% | +4.4% | |
| NICE | Buy | NICE LTD - SPON ADRsponsored adr | $11,830,000 | +15.5% | 41,650 | +0.7% | 15.08% | +20.6% |
| PROF | Buy | PROFOUND MEDICAL CORP | $11,459,000 | +29.1% | 783,655 | +44.2% | 14.60% | +34.7% |
| WIX | Buy | WIX.COM LTD | $11,209,000 | -20.4% | 57,199 | +17.9% | 14.28% | -16.9% |
| RCEL | Buy | AVITA THERAPEUTICS INC | $7,694,000 | -10.3% | 434,171 | +3.8% | 9.81% | -6.4% |
| HDB | Buy | HDFC BANK LTD-ADRsponsored ads | $5,162,000 | +107.8% | 70,630 | +107.9% | 6.58% | +116.9% |
| TAK | Buy | TAIWAN SEMICONDUCTOR-SP ADRsponsored ads | $3,157,000 | +22.4% | 28,278 | +31.7% | 4.02% | +27.7% |
| OTEX | Sell | OPEN TEXT CORP | $2,986,000 | -29.5% | 61,240 | -26.6% | 3.81% | -26.4% |
| MYOV | Buy | MYOVANT SCIENCES LTD | $2,942,000 | +1.2% | 131,094 | +2.7% | 3.75% | +5.6% |
| AXNX | Sell | AXONICS MODULATION TECHNOLOG | $2,935,000 | -17.1% | 45,099 | -19.2% | 3.74% | -13.4% |
| AUPH | Sell | AURINIA PHARMACEUTICALS INC | $2,470,000 | -54.6% | 111,608 | -73.4% | 3.15% | -52.6% |
| MSFT | MICROSOFT CORP | $1,361,000 | +4.1% | 4,826 | 0.0% | 1.74% | +8.7% | |
| BABA | Sell | ALIBABA GROUP HOLDING-SP ADRsponsored ads | $1,141,000 | -67.4% | 7,710 | -50.0% | 1.45% | -65.9% |
| CLPT | Buy | CLEARPOINT NEURO INC | $512,000 | -3.0% | 28,817 | +4.2% | 0.65% | +1.2% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MICROSOFT CORP | 14 | Q4 2021 | 20.2% |
| NICE LTD - SPON ADR | 13 | Q1 2022 | 18.1% |
| TAKEDA PHARMACEUTIC-SP ADR | 13 | Q1 2022 | 19.3% |
| WIX.COM LTD | 10 | Q1 2022 | 24.7% |
| PROFOUND MEDICAL CORP | 9 | Q1 2022 | 15.6% |
| AXONICS MODULATION TECHNOLOG | 9 | Q4 2021 | 17.4% |
| AVITA THERAPEUTICS INC | 8 | Q1 2022 | 31.8% |
| BIOHAVEN PHARMACEUTICAL HOLD | 6 | Q4 2020 | 14.9% |
| VISA INC-CLASS A SHARES | 5 | Q1 2020 | 14.9% |
| HDFC BANK LTD-ADR | 5 | Q1 2022 | 21.7% |
View Blackcrane Capital, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2022-05-12 |
| 13F-HR | 2022-02-14 |
| 13F-HR | 2021-11-12 |
| 13F-HR | 2021-08-12 |
| 13F-HR | 2021-05-13 |
| 13F-HR | 2021-02-10 |
| 13F-HR | 2020-11-12 |
| 13F-HR | 2020-08-14 |
| 13F-HR | 2020-05-14 |
| 13F-HR | 2020-02-12 |
View Blackcrane Capital, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.